Abstract | UNLABELLED: We analyzed the pattern of (11)C-acetate and (18)F-FDG uptake on PET/CT in patients with hepatocellular carcinoma (HCC). We also assessed the expression of important regulatory enzymes related to glycolysis and lipid synthesis in relation to (18)F-FDG and (11)C-acetate uptake in human HCC cell lines. The significance of (11)C-acetate uptake regulation was further evaluated with regard to cell viability. METHODS: RESULTS: In all 11 patients and 4 of the 5 cell lines, the uptake patterns of the 2 radiotracers were complementary. ACSS1 and ACSS2 were highly expressed in a cell line with low (18)F-FDG uptake and high (11)C-acetate uptake, whereas only ACSS2 was expressed in a cell line with high (18)F-FDG uptake and low (11)C-acetate uptake. Fatty acid synthase expression was seen in cells with high (18)F-FDG or (11)C-acetate uptake. These findings indicate the possibility that both glucose and acetate can be a compensatory carbon source for lipid synthesis in cancer. Transient transfection with ACSS1 or ACSS2 siRNA in cells with high (11)C-acetate uptake decreased (11)C-acetate uptake and cell viability. CONCLUSION:
|
Authors | Mijin Yun, Seong-Hye Bang, Jae Woo Kim, Jun Young Park, Kyoung Sup Kim, Jong Doo Lee |
Journal | Journal of nuclear medicine : official publication, Society of Nuclear Medicine
(J Nucl Med)
Vol. 50
Issue 8
Pg. 1222-8
(Aug 2009)
ISSN: 0161-5505 [Print] United States |
PMID | 19617323
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acetates
- Radiopharmaceuticals
- carbon-11 acetate
- Fluorodeoxyglucose F18
- Carbon
- Fatty Acid Synthases
- Acetate-CoA Ligase
|
Topics |
- Acetate-CoA Ligase
(metabolism)
- Acetates
(pharmacokinetics)
- Adult
- Aged
- Carbon
(pharmacokinetics)
- Carcinoma, Hepatocellular
(diagnostic imaging, metabolism)
- Cell Line, Tumor
- Cell Survival
- Fatty Acid Synthases
(metabolism)
- Female
- Fluorodeoxyglucose F18
(pharmacokinetics)
- Humans
- Liver Neoplasms
(diagnostic imaging, metabolism)
- Male
- Metabolic Clearance Rate
- Middle Aged
- Radionuclide Imaging
- Radiopharmaceuticals
(pharmacokinetics)
|